- Stealth Health has completed its acquisition of Kramer, a Canadian network connecting retail pharmacies with specialized compounding partners, advancing its strategy to integrate telemedicine, prescribing, medication compounding and direct-to-patient delivery.
- Kramer’s platform provides nationwide compounding access, streamlined prescription transfers and coordinated medication delivery while allowing referring pharmacies to retain their patient relationships.
- The acquisition will strengthen Stealth Health’s digital healthcare platform and white-label services for clinics, healthcare organizations and wellness brands, supporting its expansion across longevity medicine, weight management, hormone optimization and personalized care.
- The transaction closed on October 16, 2026, with financial terms undisclosed. Stealth Health plans to integrate Kramer’s network into its broader platform to connect virtual consultations with specialized pharmaceutical fulfillment across Canada.
Takeaways:
Stealth Health’s acquisition of Kramer strengthens its vertically integrated digital healthcare model by linking telemedicine and prescribing with compounding and delivery. Nationwide pharmacy connectivity and white-label services could improve fulfillment and expand B2B partnerships, particularly in weight management and hormone optimization. Regulatory compliance and integration execution will be critical to scaling the model.
Source: CA Newswire
